Abstract
Aerosol microparticles of salbutamol sulphate are gas-phase coated with an amino acid l-leucine. Depending of the saturated state of l-leucine, the coating is formed by the surface diffusion of l-leucine molecules within a droplet or by the physical vapour deposition (PVD) of l-leucine
or by the combination thereof. The PVD coated particles showed
excellent aerosolization characteristics in a carrier-free powder
delivery from an inhaler. The aerosolization of the fine powders is
compared with surface energy parameters analysed by inverse gas
chromatography (IGC). The dispersion testing is conducted by a
Inhalation Simulator using a fast inhalation profile with inhalation
flow rate of 67 l min−1. It is found that the powder emission
is affected by the morphology, surface roughness (asperity size and
density) of the particles and acidity of particle surface. The latter
affects the dispersion and dose repeatability of fine powder in a case
if l-leucine content is high enough.
However, there is no direct correlation between dispersive surface
energies and aerosolization performances of the powders. Crucial factors
for the improved aerosolization rely weakly on surface acid–base
properties but strongly on particle morphology and fine-scale surface
roughness.
Original language | English |
---|---|
Pages (from-to) | 79-85 |
Journal | International Journal of Pharmaceutics |
Volume | 385 |
Issue number | 1-2 |
DOIs | |
Publication status | Published - 2010 |
MoE publication type | A1 Journal article-refereed |
Keywords
- Aerosolization
- coating
- I-leucine
- pulmonary drug delivery
- surface energy
- surface modification